About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Guidelines Recommend Metformin to Treat Type 2 Diabetes

by Sheela Philomena on February 9, 2012 at 10:08 AM
Font : A-A+

 New Guidelines Recommend Metformin to Treat Type 2 Diabetes

The American College of Physicians (ACP) recommends metformin as the first drug to treat most patients with type 2 diabetes. ACP also recommends that clinicians add a second drug to metformin when treatment with metformin and lifestyle changes fail to control blood sugar levels.

The recommendations are part of a new ACP clinical practice guideline published today in Annals of Internal Medicine, ACP's flagship journal. ACP developed the guideline based on an analysis of the comparative effectiveness and safety of different classes of oral diabetes drugs approved by the US Food and Drug Administration for the treatment of high blood sugar in people with type 2 diabetes: metformin, sulfonylureas, meglitinides, thiazolidinediones, DPP-4 inhibitors, and GLP-1 receptor antagonists.

Advertisement

ACP evaluated the evidence of the impact of high blood sugar levels on clinical outcomes such as body weight, cholesterol and triglyceride levels, all-cause mortality, cardiovascular disease and death, neuropathy, and kidney function.

"We found that most diabetes medications reduced blood sugar levels to a similar degree," said Amir Qaseem, MD, FACP, PhD, MHA, Director of Clinical Policy at ACP. "However, metformin is more effective compared to other type 2 diabetes drugs in reducing blood sugar levels when used alone and in combination with other drugs. In addition, metformin reduces body weight and improves cholesterol profiles."
Advertisement

For side effects, the risk for dangerously low blood sugar levels was higher with sulfonylureas than with other type 2 diabetes drugs. Metformin was associated with fewer side effects than sulfonylureas.

The evidence was insufficient to show any difference in effectiveness between various medications across subgroups of adults, such as age, sex, or race.

Best Practice AdviceThe guideline includes a Best Practice Advice section to help clinicians practice high value, cost-conscious care. ACP recommends prescribing generic metformin because it has better effectiveness than the majority of the other medications; is associated with fewer adverse effects, including that it does not result in weight gain; and is less expensive.

Patient EducationThe guideline notes that good management of type 2 diabetes includes patient education.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes Otitis Media Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide Silent Killer Diseases Diabetes Facts Gestational diabetes 

Most Popular on Medindia

Color Blindness Calculator Drug - Food Interactions Iron Intake Calculator Post-Nasal Drip Hearing Loss Calculator Indian Medical Journals Sinopril (2mg) (Lacidipine) Drug Side Effects Calculator Loram (2 mg) (Lorazepam) Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Guidelines Recommend Metformin to Treat Type 2 Diabetes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests